HEALTHDAY - CLINICAL TRIALS
5/16/2013
New Drug May Help Immune System Fight Cancer
Posted 7:00 AM 5/16/2013 by By Brenda Goodman
HealthDay Reporter
THURSDAY, May 16 (HealthDay News) -- An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom other treatments have failed, an early study shows.
The drug binds to a protein called PD-L1 that sits on the surface of cancer (More)
5/1/2013
Girls With Autism May Need Different Treatments Than Boys
Posted 10:00 AM 5/1/2013 by By Serena Gordon
HealthDay Reporter
WEDNESDAY, May 1 (HealthDay News) -- With four to five times more males affected by autism spectrum disorders than females, much less is known about girls with autism.
Fortunately, more research is beginning to focus on autism in girls, said Geraldine Dawson, chief science officer of (More)
4/29/2013
HIV 'Cure' Looks 'Promising,' Danish Scientists Contend
Posted 10:00 AM 4/29/2013 by HealthDay staff
MONDAY, April 29 (HealthDay News) -- Danish scientists testing a novel HIV treatment in human trials contend that they're confident their strategy will result in a cure for the AIDS-causing virus, according to news reports.
The technique -- already tested successfully in lab experiments (More)
4/18/2013
Clinical Trials Helped One Woman's Fight Against Cancer
Posted 10:00 AM 4/18/2013 by By Barbara Bronson Gray
HealthDay Reporter
THURSDAY, April 18 (HealthDay News) -- Monica Barlow, a 35-year-old from Maryland, was training for a half-marathon when she noticed she couldn't shake a bad cough and ongoing fatigue. After a couple of rounds of antibiotics from an urgent care clinic didn't work, she sought another opinion.
(More)...4/6/2013
Experimental Vaccine Shows Promise for Ovarian Cancer
Posted 12:00 PM 4/6/2013 by By Randy Dotinga
HealthDay Reporter
SATURDAY, April 6 (HealthDay News) -- A novel but preliminary new treatment for ovarian cancer has apparently produced complete remission for one patient with an advanced form of the disease, researchers are reporting.
The promising results of a phase 1 clinical trial for the immunotherapy (More)
As Seen On News 5
Social
Most Popular
Please select a Position and an Ad Zone.
